Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.
Di Caro S, Ojetti V, Zocco MA, Cremonini F, Bartolozzi F, Candelli M, Lupascu A, Nista EC, Cammarota G, Gasbarrini A. Di Caro S, et al. Among authors: lupascu a. Aliment Pharmacol Ther. 2002 Mar;16(3):527-32. doi: 10.1046/j.1365-2036.2002.01165.x. Aliment Pharmacol Ther. 2002. PMID: 11876707 Free article. Clinical Trial.
Probiotics in antibiotic-associated diarrhoea.
Cremonini F, Di Caro S, Santarelli L, Gabrielli M, Candelli M, Nista EC, Lupascu A, Gasbarrini G, Gasbarrini A. Cremonini F, et al. Among authors: lupascu a. Dig Liver Dis. 2002 Sep;34 Suppl 2:S78-80. doi: 10.1016/s1590-8658(02)80171-2. Dig Liver Dis. 2002. PMID: 12408447
Probiotics and Helicobacter pylori eradication.
Canducci F, Cremonini F, Armuzzi A, Di Caro S, Gabrielli M, Santarelli L, Nista E, Lupascu A, De Martini D, Gasbarrini A. Canducci F, et al. Among authors: lupascu a. Dig Liver Dis. 2002 Sep;34 Suppl 2:S81-3. doi: 10.1016/s1590-8658(02)80172-4. Dig Liver Dis. 2002. PMID: 12408448
Helicobacter pylori infection in patients with Hashimoto's thyroiditis.
Franceschi F, Satta MA, Mentella MC, Penland R, Candelli M, Grillo RL, Leo D, Fini L, Nista EC, Cazzato IA, Lupascu A, Pola P, Pontecorvi A, Gasbarrini G, Genta RM, Gasbarrini A. Franceschi F, et al. Among authors: lupascu a. Helicobacter. 2004 Aug;9(4):369. doi: 10.1111/j.1083-4389.2004.00241.x. Helicobacter. 2004. PMID: 15270751 No abstract available.
Infliximab in the treatment of steroid-dependent ulcerative colitis.
Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A. Armuzzi A, et al. Among authors: lupascu a. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct;8(5):231-3. Eur Rev Med Pharmacol Sci. 2004. PMID: 15638236 Clinical Trial.
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.
Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, Cammarota G, Tondi P, Pola P, Gasbarrini G, Gasbarrini A. Nucera G, et al. Among authors: lupascu a. Aliment Pharmacol Ther. 2005 Jun 1;21(11):1391-5. doi: 10.1111/j.1365-2036.2005.02493.x. Aliment Pharmacol Ther. 2005. PMID: 15932370 Free article.
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.
Lauritano EC, Gabrielli M, Lupascu A, Santoliquido A, Nucera G, Scarpellini E, Vincenti F, Cammarota G, Flore R, Pola P, Gasbarrini G, Gasbarrini A. Lauritano EC, et al. Among authors: lupascu a. Aliment Pharmacol Ther. 2005 Jul 1;22(1):31-5. doi: 10.1111/j.1365-2036.2005.02516.x. Aliment Pharmacol Ther. 2005. PMID: 15963077 Free article. Clinical Trial.
56 results